Related Experiment Video
Updated: Sep 3, 2025
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
A difficult diagnosis of anaplasmosis with pneumonia: A case report
Canan Taşdemir1, Sümeyra Şimşek1, Uğur Önal1
1Department of Infectious Diseases and Clinical Microbiology, 64048Uludag University, Faculty of Medicine, Bursa, Turkey.
Abstract:
Anaplasmosis (Human Granulocytic Anaplasmosis, HGA), is a disease caused by Anaplasma phagocytophilum but also formerly known as Ehrlichia phagocytophilum and Ehrlichia equi. We present a 57-year-old male diagnosed with systemic HGA and lung involvement, who had lived in Benin. A possible tick bite had been reported in his history. There was a dramatic response to treatment.
Insights
Anaplasmosis, a tick-borne illness, can affect the lungs. This case study shows a patient in Benin with severe Anaplasmosis who significantly improved with treatment.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Anaplasmosis, caused by *Anaplasma phagocytophilum*, is an emerging tick-borne illness.
- The disease, previously known as Human Granulocytic Anaplasmosis (HGA), presents diagnostic challenges.
- Geographic distribution and clinical manifestations are continually being documented.
Observation:
- A 57-year-old male with a history of potential tick exposure presented with systemic Anaplasmosis.
- The patient, residing in Benin, exhibited significant lung involvement.
- Clinical presentation included symptoms indicative of severe systemic infection.
Findings:
- Diagnosis of systemic Human Granulocytic Anaplasmosis (HGA) was confirmed.
- Pulmonary complications were a key feature of the illness.
- Prompt and appropriate treatment led to a remarkable recovery.
Implications:
- Highlights the importance of considering Anaplasmosis in febrile illnesses, even in non-endemic areas.
- Underscores the potential for severe lung involvement in Anaplasmosis.
- Demonstrates the efficacy of timely treatment for Anaplasmosis, improving patient outcomes.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:29Pneumonia II: Pathophysiology